MARKET

DMAAR

DMAAR

Drugs Made In Amer Acqutn Corp
NASDAQ
0.1270
0.0000
0.00%
Closed 13:35 09/04 EDT
OPEN
0.1250
PREV CLOSE
0.1270
HIGH
0.1270
LOW
0.1226
VOLUME
1.38K
TURNOVER
--
52 WEEK HIGH
0.2433
52 WEEK LOW
0.0400
MARKET CAP
--
P/E (TTM)
0.6056
1D
5D
1M
3M
1Y
5Y
1D
DRUGS MADE IN AMERICA ACQUISITION CORP. FORM 10-Q
Press release · 08/15 01:41
Weekly Report: what happened at DMAAR last week (0908-0912)?
Weekly Report · 09/15/2025 12:31
Weekly Report: what happened at DMAAR last week (0901-0905)?
Weekly Report · 09/08/2025 12:33
About DMAAR
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.

Webull offers Drugs Made In America Acquisition Corp stock information, including NASDAQ: DMAAR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DMAAR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DMAAR stock methods without spending real money on the virtual paper trading platform.